Pityriasis alba
Reading File
Finding Sources
Searching PubMed
pityriasis alba
Searching the Web
pityriasis alba clinical features diagnosis treatment 2025
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I have sufficient data from the dermatology textbook and family medicine textbook. Let me now compile a comprehensive answer.
Pityriasis Alba
Definition and Overview
Pityriasis alba (PA) is a very common, benign, self-limited hypopigmentary dermatosis of childhood and adolescence. The name is descriptive - pityriasis refers to the characteristic fine scale, and alba to its pale color. It is widely regarded as a minor manifestation of atopic dermatitis (AD) and is associated with a history of atopy.
- Prevalence: affects approximately 5% of children worldwide; in the US, may affect nearly one third of school-age children
- Age: typically 3-16 years, though it can occur outside this range
- More noticeable in darkly pigmented individuals (greater contrast with surrounding skin)
- No significant sex predilection
Pathogenesis
The exact etiology is unknown. PA is most commonly seen in patients with a personal or family history of atopic dermatitis, allergic rhinitis, or asthma. The hypopigmentation results from:
- Reduced number of active melanocytes in affected skin
- Decreased number and size of melanosomes
- These findings are demonstrated on light and electron microscopy
Sun exposure worsens the cosmetic appearance by tanning surrounding normal skin, making lesions more prominent in summer months.
Clinical Features
Phases of the lesion:
- Early/active phase: faint erythema and mild scaling (pink macules)
- Intermediate phase: erythema fades, leaving dry, whitish, powdery patches with a slightly raised pinkish border
- Late phase: pure hypopigmented macules/patches - the stage most patients present with
Morphology:
- Ill-defined, round to oval macules and patches
- Size: typically 0.5-3 cm (larger lesions can occur)
- Mild fine scaling
- Mild to moderate hypopigmentation (not complete depigmentation)
- Occasional pruritus or burning (mostly asymptomatic)
Distribution:
- Face - especially the malar (cheek) region (most common site)
- Neck, shoulders, trunk, upper extremities
- Multiple lesions are typical
Variant - Extensive Pityriasis Alba (EPA):
- More common in adults
- More generalized, truncal distribution
- Lesions are not preceded by erythema and tend to be more persistent
Investigations
PA is primarily a clinical diagnosis. Investigations used when the diagnosis is uncertain:
| Investigation | Finding |
|---|---|
| Wood's lamp | Reveals more lesions; shows decrease but not absence of pigment (unlike vitiligo, where fluorescence is absent) |
| Dermoscopy | Mild follicular and interfollicular hypopigmentation with fine scaling |
| Biopsy (rarely needed) | Spongiosis, mild perivascular infiltrate, reduced melanocytes, decreased melanosomes |
| KOH scraping | Negative (helps rule out tinea versicolor) |
Differential Diagnosis
| Condition | Distinguishing Features |
|---|---|
| Vitiligo | Complete depigmentation (chalk-white), sharp borders, no scale, Wood's lamp shows bright white fluorescence |
| Tinea versicolor | KOH positive (hyphae + spores), more scaling, trunk predominance |
| Pityriasis lichenoides chronica | More scaly, extrafacial lesions, may scar |
| Eruptive hypomelanosis | Associated viral prodrome |
| Post-inflammatory hypopigmentation | Prior inflammation or trauma in the same area |
| Leprosy | Hypoesthesia, nerve thickening, endemic area |
| Hypopigmented mycosis fungoides | More persistent, pruritic, trunk/extremities, biopsy shows atypical lymphocytes |
A key differentiator: Wood's lamp shows incomplete pigment loss in PA vs. complete loss in vitiligo.
Treatment
PA is self-limited and usually resolves spontaneously - often by puberty. The goals of management are reassurance, symptom relief, and cosmetic improvement.
General measures:
- Reassure patient/parents about the benign, self-limiting nature
- Emollients - first-line; reduce scaling and dryness; may be equally effective as steroids
- Sun protection (prevents contrast accentuation)
Topical agents:
| Agent | Evidence |
|---|---|
| Hydrocortisone 1% cream or ointment | First-line low-potency steroid; limit use to 2 weeks on the face |
| Tacrolimus 0.03% ointment | Effective; calcineurin inhibitor - avoids steroid side effects |
| Calcitriol (topical vitamin D analogue) | Comparable efficacy to tacrolimus in controlled trials |
| Calcipotriol 0.005% cream | Studied vs. tacrolimus and steroids; all showed benefit over placebo |
| Emollients | Equally effective as topical steroids for most patients |
- Phototherapy: limited evidence; sun exposure that tans surrounding skin can paradoxically worsen cosmetic appearance
Prognosis
- Generally excellent; lesions fade by adulthood in the majority
- Some patches may remain stationary and unchanged for several years before clearing
- Patients with extensive or persistent disease may benefit from active treatment
- No systemic complications
Key Points Summary
- Common benign hypopigmentary condition, considered a minor form of atopic dermatitis
- Presents as ill-defined hypopigmented macules with fine scale on the cheeks/face of children
- Wood's lamp: decreased (not absent) pigmentation distinguishes it from vitiligo
- Diagnosis is clinical; KOH scraping rules out tinea versicolor
- Treatment: reassurance + emollients first; short-course hydrocortisone 1% or tacrolimus if needed
- Self-limited; resolves by puberty in most cases
Sources: Dermatology 2-Volume Set 5e, p. 1324 | Textbook of Family Medicine 9e, p. 923
Literature note: No recent (2024-2026) systematic reviews or meta-analyses on pityriasis alba were identified in PubMed, reflecting that the condition is well-characterized with stable management principles and primarily managed by clinical guidelines rather than ongoing trial activity.
This is a shared conversation. Sign in to Orris to start your own chat.